Wallen M D, Radhakrishnan J, Appel G, Hodgson M E, Pablos-Mendez A
Division of Epidemiology, Columbia University School of Public Health, New York, NY, USA.
Clin Nephrol. 2001 Feb;55(2):101-8.
End-stage renal disease (ESRD) is associated with an overall one-year mortality of 23.5% in the US, of which cardiac causes constitute 50% of all deaths. Data on incident ESRD patients were obtained from the Health Care Financing Administration's 2728 and 2746 forms by special request from the ESRD Network of New York. 4,948 ESRD patients, who started dialysis in New York State from April 1, 1995, through April 1, 1996, were assessed to identify risk factors present at the initiation of dialysis that predict cardiac death. 899 deaths were registered during the 19-month-follow-up period, 50% of which were from cardiac causes. Using the Cox-proportional hazards model, the increasing age category, white race, the presence of one or more vascular co-morbid conditions, and the presence of diabetes and one or more cardiac co-morbid conditions significantly predicted cardiac death (p < 0.05). Diabetes increased the risk for cardiac death by 48% for those patients without any cardiac co-morbidities (RR = 1.48, p < 0.0082). In contrast with results observed in the general population, gender, serum albumin and body mass index were not significant predictors of cardiac death. In identifying risk factors present at the initiation ofdialysis that predict cardiac death, this study highlights factors that may be modified prior to dialysis initiation in order to improve life expectancy and mortality rates and decrease health care costs for the ESRD population.
在美国,终末期肾病(ESRD)患者的总体一年死亡率为23.5%,其中心脏病因导致的死亡占所有死亡人数的50%。终末期肾病新发病例患者的数据是应纽约终末期肾病网络的特别要求,从医疗保健财务管理局的2728表和2746表中获取的。对1995年4月1日至1996年4月1日在纽约州开始透析的4948例终末期肾病患者进行评估,以确定透析开始时存在的可预测心脏死亡的危险因素。在19个月的随访期内记录了899例死亡病例,其中50%是由心脏病因导致的。使用Cox比例风险模型,年龄增长、白人种族、存在一种或多种血管合并症、患有糖尿病以及存在一种或多种心脏合并症显著预测了心脏死亡(p<0.05)。对于没有任何心脏合并症的患者,糖尿病使心脏死亡风险增加了48%(风险比=1.48,p<0.0082)。与普通人群中观察到的结果相反,性别、血清白蛋白和体重指数并不是心脏死亡的显著预测因素。在确定透析开始时存在的可预测心脏死亡的危险因素时,本研究强调了在透析开始前可能加以改变的因素,以便提高预期寿命和降低死亡率,并降低终末期肾病患者的医疗保健成本。